DoW Breast Cancer, Transformative Breast Cancer Consortium Award
Funds a large, multi-institution team of scientists, clinicians and advocates tackling one breast cancer problem too big for a single lab.
Some breast cancer problems are too big for one lab to solve alone β they need scientists, clinicians and the people actually living with the disease working together, at a scale a single investigator could never assemble.
This award funds exactly that kind of team: a synergistic, highly integrated, multi-institutional consortium built around one major breast cancer problem, aiming for a transforβ¦
A large multidisciplinary, multi-institutional consortium of up to five Principal Investigators pursuing one synergistic, transformative breast cancer research effort, addressing at least one FY26 BCRP overarching challenge. Each project team must include at least one breast cancer consumer advocate, and the award is a cooperative agreement.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up